This site has been optimized to work with modern browsers and does not fully support your version of Internet Explorer.

EnzBond launches to make fast, effective enzyme development realisty

EnzBond, a new biotechnology company from Oxford University, has been formed to commercialise in-silico technology, which makes utilising enzymes in drug manufacturing both cost-effective and time-efficient

Full story on Oxford University website